|
|
|
Insider
Information: |
Mueller Brian |
Relationship: |
|
City: |
Novato |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
82,159 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$6,395,452 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
82,159 |
|
|
Total
Value |
$6,395,452 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-05-30 |
72,159 |
|
0 |
Premium* |
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
139 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-04-30 |
4 |
A |
$19.35 |
$12,846 |
D/D |
664 |
8,964 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2013-05-12 |
4 |
D |
$67.68 |
$55,295 |
D/D |
(817) |
8,107 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2011-10-31 |
5 |
B |
$13.23 |
$12,750 |
D/D |
964 |
8,300 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2021-03-15 |
4 |
D |
$78.39 |
$77,920 |
D/D |
(994) |
37,806 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2021-02-03 |
4 |
D |
$82.82 |
$88,700 |
D/D |
(1,071) |
28,673 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2022-02-03 |
4 |
D |
$87.77 |
$94,089 |
D/D |
(1,072) |
29,709 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2019-03-15 |
4 |
D |
$94.53 |
$108,615 |
D/D |
(1,149) |
11,248 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Acting CFO |
|
2020-03-13 |
4 |
D |
$84.50 |
$110,104 |
D/D |
(1,303) |
18,465 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2011-04-29 |
4 |
A |
$11.64 |
$17,466 |
D/D |
1,501 |
2,613 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2011-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
4,175 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-05-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
15,246 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2022-03-15 |
4 |
D |
$78.27 |
$146,208 |
D/D |
(1,868) |
38,881 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2013-03-01 |
4 |
S |
$59.81 |
$120,510 |
D/D |
(2,015) |
13,279 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2018-06-15 |
4 |
AS |
$94.50 |
$190,985 |
D/D |
(2,021) |
13,029 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2013-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
2,200 |
8,860 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2018-05-10 |
4 |
AS |
$89.50 |
$219,275 |
D/D |
(2,450) |
15,396 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2018-06-22 |
4 |
OE |
$28.23 |
$70,321 |
D/D |
2,491 |
14,866 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-07-10 |
4 |
AS |
$42.50 |
$106,250 |
D/D |
(2,500) |
15,340 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
|
2012-07-10 |
4 |
OE |
$14.39 |
$35,975 |
D/D |
2,500 |
17,840 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2018-08-07 |
4 |
AS |
$104.50 |
$261,250 |
D/D |
(2,500) |
12,375 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
|
2018-08-07 |
4 |
OE |
$28.23 |
$70,575 |
D/D |
2,500 |
14,875 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2022-12-13 |
4 |
AS |
$107.50 |
$268,750 |
D/D |
(2,500) |
27,746 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2022-12-13 |
4 |
OE |
$63.10 |
$157,750 |
D/D |
2,500 |
30,246 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2023-01-13 |
4 |
AS |
$114.50 |
$286,250 |
D/D |
(2,500) |
27,746 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
|
2023-01-13 |
4 |
OE |
$63.10 |
$157,750 |
D/D |
2,500 |
30,246 |
0 |
- |
|
139 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|